Diageo Board Appoints Debra Crew Interim CEO
5 June 2023, London, UK:
Sir Ivan Menezes is currently in hospital receiving treatment for medical conditions including a stomach ulcer. Over the weekend, we learned that Ivan's recovery suffered a significant setback due to complications, which followed emergency surgery on the ulcer.
As a result of these developments, the Board of Directors has appointed Debra Crew Interim Chief Executive Officer with immediate effect, ahead of her appointment as Chief Executive Officer and joining the Board as an executive director on 1 July 2023. As previously announced, Ivan will retire from the Board on 30 June 2023.
Our thoughts are with our much-loved colleague, Ivan, and his family.
Out of respect for Ivan and his family's privacy, we will not be commenting further at this time.
ENDS
| Investor relations: Durga Doraisamy | +44 (0) 7902 126906 |
| | |
| Media relations: Dominic Redfearn | +44 (0) 7971 9777 59
|
About Diageo
Diageo is a global leader in beverage alcohol with an outstanding collection of brands across spirits and beer categories. These brands include Johnnie Walker, Crown Royal, J&B and Buchanan's whiskies, Smirnoff, Cîroc and Ketel One vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray and Guinness.
Diageo is a global company, and our products are sold in more than 180 countries around the world. The company is listed on both the London Stock Exchange (DGE) and the New York Stock Exchange (DEO). For more information about Diageo, our people, our brands, and performance, visit us at www.diageo.com. Visit Diageo's global responsible drinking resource, www.DRINKiQ.com for information, initiatives, and ways to share best practice.
Celebrating life, every day, everywhere.
Diageo plc LEI: 213800ZVIELEA55JMJ32
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
